Omega-3 Supplementation Modulates Whole-Blood EPA and DHA Without Improving Patient-Reported Outcomes in Youth with Migraine: A Quasi-Randomized Pilot Trial.
Nutrients · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansMigraine DisordersEicosapentaenoic AcidAdolescentChildPilot ProjectsFemaleDietary SupplementsDocosahexaenoic AcidsMaleDouble-Blind MethodPatient Reported Outcome MeasuresFatty Acids, Omega-3Treatment Outcomedietary supplementationlipid biomarkersomega-3 fatty acidspediatric migraine
Come citare questo studio
Samantha Glover, Anne E Sanders, Daisy Zamora, Keturah R Faurot, Saame Raza Shaikh, Kimon Divaris, Klaus Werner, Steven P Trau, Jaclyn Bain, Jialiu Xie, Sydney Danze, Sajan Singh, Thomas Southern, Joseph Iskander, Caroline M Sawicki. (2026). Omega-3 Supplementation Modulates Whole-Blood EPA and DHA Without Improving Patient-Reported Outcomes in Youth with Migraine: A Quasi-Randomized Pilot Trial.. Nutrients. DOI: 10.3390/nu18182983
Consulta la pubblicazione originale ↗